Provided by Tiger Fintech (Singapore) Pte. Ltd.

Blueprint Medicines

127.85
-0.0500-0.04%
Post-market: 127.76-0.0900-0.07%16:29 EDT
Volume:3.07M
Turnover:392.42M
Market Cap:8.27B
PE:-52.11
High:128.07
Open:128.07
Low:127.77
Close:127.90
Loading ...

Blueprint Medicines Up Over 26%, on Track for Record High Close and Record Percent Increase -- Data Talk

Dow Jones
·
02 Jun

Blueprint Medicines Corp : Leerink Partners Raises Target Price to $129 From $93

THOMSON REUTERS
·
02 Jun

Blueprint Medicines Shares Jump 26.2% to Record High After France's Sanofi to Buy Co for up to $9.5 Bln

THOMSON REUTERS
·
02 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Xilio Therapeutics, Red Rock Resorts, Kymera

Reuters
·
02 Jun

Blueprint Medicines Cut to Hold From Buy by Needham

Dow Jones
·
02 Jun

Needham downgrades Blueprint Medicines (BPMC) to a Hold

TIPRANKS
·
02 Jun

Blueprint Medicines Corp : Needham Cuts to Hold From Buy

THOMSON REUTERS
·
02 Jun

Deals of the day-Mergers and acquisitions

Reuters
·
02 Jun

Blueprint Medicines downgraded to Neutral from Outperform at Wedbush

TIPRANKS
·
02 Jun

Wedbush Downgrades Blueprint Medicines to Neutral From Outperform, Lifts Price Target to $129 From $128

MT Newswires Live
·
02 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Blueprint Medicines, Boeing

Reuters
·
02 Jun

5 Things to Know Before the Stock Market Opens

Investopedia
·
02 Jun

S&P 500 Futures Decline In Premarket Trading; Blueprint Medicines, Steel Dynamics Lead

Dow Jones
·
02 Jun

Sanofi’s Strategic Acquisition of Blueprint Medicines: A Buy Recommendation by Derek Archila

TIPRANKS
·
02 Jun

Blueprint Medicines Corp: Sanofi to Pay $500 Mln to Co IF Deal Is Terminated Under Certain Circumstances

THOMSON REUTERS
·
02 Jun

Blueprint Medicines Shares up 27.1% Premarket After France's Sanofi to Buy Co for up to $9.5 Bln

THOMSON REUTERS
·
02 Jun

U.S. Stocks to Watch: Cleveland-Cliffs, Steel Dynamics, Tesla, NIO, Blueprint Medicines, and More

Dow Jones
·
02 Jun

Blueprint Medicines Soars 26% as Sanofi to Buy the US Biopharma Group in $9.1 Bln Deal

Bloomberg
·
02 Jun

Sanofi to Acquire Blueprint Medicines, Expanding Portfolio in Rare Immunological Disease and Adding Early-Stage Pipeline in Immunology

THOMSON REUTERS
·
02 Jun

Blueprint Shareholders Will Receive One Non-Tradeable Contingent Value Right (CVR) Which Will Entitle Holder to Receive Two Potential Milestone Payments of $2 and $4 per CVR for Achievement, Respectively, of Future Development and Regulatory Milestones for Blu-808

THOMSON REUTERS
·
02 Jun